Researchers link GLP-1 drugs to lower tuberculosis risk in type 2 diabetesResearchers link GLP-1 drugs to lower tuberculosis risk in type 2 diabetes ++

Researchers link GLP-1 drugs to lower tuberculosis risk in type 2 diabetesResearchers link GLP-1 drugs to lower tuberculosis risk in type 2 diabetes https://www.news-medical.net/news/20260824/Researchers-link-GLP-1-drugs-to-lower-tuberculosis-risk-in-type-2-diabetes.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=tuberculosis_newsletter_25_august_2026 A large retrospective cohort study found that GLP-1 receptor agonist use was associated with a lower risk of tuberculosis in people with type 2 diabetes compared with sulfonylureas, metformin, DPP-4 inhibitors, and SGLT2 inhibitors. TB preventive treatment delivers real-world gains for people with HIVTB preventive treatment delivers real-world gains for people with HIV https://www.news-medical.net/news/20260817/TB-preventive-treatment-delivers-real-world-gains-for-people-with-HIV.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=tuberculosis_newsletter_25_august_2026 Tuberculosis (TB) is responsible for about a quarter of all AIDS deaths. In 2024, it was also the leading cause of death among people with HIV. This is despite TB being a preventable and curable disease.